Has Jeremy Moore, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,802 in general payments to Jeremy Moore, MD across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeremy Moore, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeremy Moore, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeremy Moore, MD

Otolaryngology · Norman, OKNPI 1184707143

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,304, 3.4 times the $378 reported in 2019.

$3,802in general payments, 2019–2025

Across 100 payments — averaging $38.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$890
Sanofi$547
Intersect ENT, Inc.$508
Inspire Medical Systems, Inc.$433
Integra Lifesciences Corporation$348
Medtronic$325
plus $752 from 13 others

What the payments were for

Travel & lodging$100%
Food & beverage$3,792100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	26	$890
Sanofi	19	$547
Intersect ENT, Inc.	9	$508
Inspire Medical Systems, Inc.	9	$433
Integra Lifesciences Corporation	3	$348
Medtronic	2	$325
Stryker	5	$144
GSK	6	$143
Paratek Pharmaceuticals, Inc.	1	$116
Optinose US, Inc.	3	$57
Sanofi-aventis U.S. LLC	2	$43
Kaleo, Inc.	3	$42
Hikma Pharmaceuticals USA	2	$34
Cook Medical LLC	2	$33
Merck	2	$32
Novartis	2	$30
Arbor Pharmaceuticals, Inc.	2	$30
Aerin Medical Inc.	1	$26
Acclarent, Inc	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,802 in reported general payments places this provider in the 80th percentile of 109 otolaryngology providers in Oklahoma.

See all otolaryngology providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$135,902

Medicare patients

539

Services billed

4,874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent SyringeDupilumab	11	$43,799
Ipratropium Bromide	78	$1,944
Fluticasone Propionate	67	$1,269
Nystatin	20	$530
Ofloxacin	24	$344
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$322
Montelukast Sodium	15	$241
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip	20	$207
Mupirocin	35	$203
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$143
Fluconazole	14	$110
Omeprazole	16	$87
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	17	$78

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Norman

Jeffrey BuytenNorman$4K
Christopher PaskowskiNorman$3K
Kibwei McKinneyOklahoma City$315K
Richard BakerOklahoma City$17K
Edward El RassiOklahoma City$13K
Benjamin CollinsOklahoma City$10K
Keith ClarkOklahoma City$6K
Emily WhiteEdmond$6K
Erica RomanoEdmond$6K
Rachad MhawejOklahoma City$6K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →